CG Oncology, Inc. (CGON) › Operating IncomeCG Oncology, Inc. (CGON) — Operating IncomeAnnual figures by period end, from SEC filings.2023-12-31: -$55.45M2024-12-31: -$114.67M2025-12-31: -$190.77M-$190.77M2023-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$190.77M—2026-02-27From 2025-01-012024-12-31-$114.67M—2026-02-27From 2024-01-012023-12-31-$55.45M—2026-02-27From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)